Virtus ETF Advisers LLC Biogen Inc. Transaction History

Virtus ETF Advisers LLC

$206 Million
Q3 2024

A detailed history of Virtus ETF Advisers LLC transactions in Biogen Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 1,408 shares of BIIB stock, worth $209,820. This represents 0.13% of its overall portfolio holdings.

Number of Shares

1,408

Previous 1,408 -0.0%

Holding current value

$209,820

Previous $326,000 16.56%

% of portfolio

0.13%

Previous 0.17%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$190.52 - $236.72 $14,860 - $18,464	-78 Reduced 5.25%	1,408 $326,000
Q1 2024 May 15, 2024	BUY	$212.02 - $267.71 $45,372 - $57,289	214 Added 16.82%	1,486 $320,000
Q4 2023 Feb 15, 2024	BUY	$222.59 - $267.94 $56,983 - $68,592	256 Added 25.2%	1,272 $329,000
Q3 2023 Nov 07, 2023	SELL	$253.3 - $285.89 $32,675 - $36,879	-129 Reduced 11.27%	1,016 $261,000
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $22,295 - $25,762	81 Added 7.61%	1,145 $326,000
Q1 2023 May 15, 2023	BUY	$256.56 - $292.34 $4,361 - $4,969	17 Added 1.62%	1,064 $295,000
Q4 2022 Feb 14, 2023	SELL	$252.44 - $306.72 $42,409 - $51,528	-168 Reduced 13.83%	1,047 $289,000
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $3,893 - $5,369	20 Added 1.67%	1,215 $324,000
Q2 2022 Aug 12, 2022	SELL	$187.54 - $223.02 $78,204 - $92,999	-417 Reduced 25.87%	1,195 $244,000
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $107,705 - $138,417	481 Added 42.53%	1,612 $387,000
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $27,733 - $36,166	-98 Reduced 7.97%	1,131 $320,000
Q2 2021 Aug 10, 2021	SELL	$259.0 - $414.71 $342,139 - $547,831	-1,321 Reduced 51.8%	1,229 $426,000
Q1 2021 May 17, 2021	BUY	$242.95 - $284.63 $16,520 - $19,354	68 Added 2.74%	2,550 $713,000
Q4 2020 Feb 12, 2021	BUY	$236.26 - $355.63 $91,905 - $138,340	389 Added 18.59%	2,482 $608,000
Q3 2020 Nov 13, 2020	BUY	$264.77 - $305.71 $32,037 - $36,990	121 Added 6.14%	2,093 $594,000
Q2 2020 Aug 05, 2020	SELL	$258.66 - $342.55 $11,639 - $15,414	-45 Reduced 2.23%	1,972 $528,000
Q1 2020 May 14, 2020	SELL	$268.85 - $341.04 $55,114 - $69,913	-205 Reduced 9.23%	2,017 $638,000
Q4 2019 Feb 13, 2020	SELL	$220.06 - $304.07 $208,616 - $288,258	-948 Reduced 29.91%	2,222 $659,000
Q3 2019 Nov 12, 2019	SELL	$217.44 - $243.88 $83,931 - $94,137	-386 Reduced 10.85%	3,170 $738,000
Q2 2019 Aug 13, 2019	BUY	$219.29 - $241.72 $258,762 - $285,229	1,180 Added 49.66%	3,556 $832,000
Q1 2019 May 14, 2019	BUY	$216.71 - $338.96 $101,203 - $158,294	467 Added 24.46%	2,376 $562,000
Q4 2018 Feb 05, 2019	SELL	$278.5 - $352.75 $181,582 - $229,993	-652 Reduced 25.46%	1,909 $574,000
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $50,777 - $66,402	173 Added 7.24%	2,561 $905,000
Q2 2018 Aug 10, 2018	SELL	$257.52 - $306.91 $112,793 - $134,426	-438 Reduced 15.5%	2,388 $693,000
Q1 2018 May 14, 2018	SELL	$260.13 - $367.91 $42,661 - $60,337	-164 Reduced 5.48%	2,826 $774,000
Q4 2017 Feb 14, 2018	SELL	$307.64 - $344.58 $336,865 - $377,315	-1,095 Reduced 26.81%	2,990 $953,000
Q2 2017 Aug 14, 2017	BUY	N/A	4,085	4,085 $1.11 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account

Virtus ETF Advisers LLC Biogen Inc. Transaction History